RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced that it will participate in Solos Endoscopy’s preferred convertible share offering by exchanging approximately 4 million restricted common shares of Solos for the preferred convertible shares being offered.
